On 16 January U.S.-based Gilead Sciences Inc (NASDAQ:GILD) appeal the Indian patent office’s rejection of its application for hepatitis C drug Sovaldi, a move that could allow local drugmakers to launch cheaper generic versions of the $1,000-a-pill medicine. On Wednesday shares of Gilead Sciences Inc. (NASDAQ:GILD) closed at $103.58. Company’s sales growth for last 5 years was 16.00% and EPS growth for next 5 years is recorded as 33.42%.
Boston Scientific Corporation (NYSE:BSX) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year ended December 31, 2014 on Wednesday, February 4, 2015 at 8:00 a.m. ET. Boston Scientific Corporation (NYSE:BSX) in last trading activity increased 0.42% to close at $14.39. Company weekly performance is -0.76% while its quarterly performance stands at 23.94%. Boston Scientific Corporation (NYSE:BSX) is -2.90% away from its 52 week high.
Resource Capital Corp. (NYSE:RSO) announced that it will release its fourth quarter and fiscal year ended December 31, 2014 operating results on Wednesday, February 25, 2015, after market hours, and invites investors and other interested parties to listen to the live webcast of its conference call on Thursday, February 26, 2015, at 8:30 a.m. Eastern Time. On last trading day Resource Capital Corp. (NYSE:RSO) moved down -0.85% to close at $4.67. Its volatility for the week is 1.54% while volatility for the month is 1.76%. RSO’s sales growth for past 5 years was 1.40% and its EPS growth for past 5 years was 36.60%. Resource Capital Corp. (NYSE:RSO) monthly performance is -7.52%.
Celanese Corporation (NYSE: CE), a global technology and specialty materials company, announced that it will host a conference call to discuss its fourth quarter 2014 results on Friday, January 23, 2015, beginning at 10:00 a.m. Eastern time. Celanese Corporation (NYSE:CE) has 0.20% insider ownership while its institutional ownership stands at 98.90%. In last trading activity company’s stock closed at $58.05.
BBVA Banco Frances S.A. (ADR) (NYSE:BFR) Short interest is confirmed a change of -36.58% in the preceding 1-month. In the 3-month period, the short interest has registered a change of 72.32%. On last trading day BBVA Banco Frances SA (NYSE:BFR) moved down -0.61% to close at $14.75. Its volatility for the week is 3.94% while volatility for the month is 3.30%. BFR’s sales growth for past 5 years was 29.30% and its EPS growth for past 5 years was 17.50%. BBVA Banco Frances SA (NYSE:BFR) monthly performance is 12.42%.